December 22, 2022
Happy Holidays from HOMERuN!
The Hospital Medicine Reengineering Network (HOMERuN) is a rapidly growing collaborative made up of more than 50 Hospital Medicine groups from academic and non-academic hospitals across the United States.
During this special time of the year, we want to acknowledge and highlight how essential your contributions to HOMERuN have been. We do important work together — work that helps our patients and colleagues and makes real impact in the world. Thank you from the bottom of our hearts! 
May your holiday season be full of health, rejuvenation, and happiness, whether caring for patients or with friends and loved ones.
Successes in 2022
HOMERuN with multiple hits at HM 2022:
At SHM Converge, HOMERuN research was represented by 2 plenaries, 2 oral presentations, 6 research posters, 1 innovation poster, and 11 clinical vignettes. Presentations from this meeting are searchable here.
HOMERuN collaborative teams supported high-impact publications:
HOMERuN teams provided important feedback to policymakers:
The Antiracism, Health Equity, and Justice team supported important work by David Sterken, who submitted a statement to the FDA on pulse oximeters and racial bias, summarized the FDA Panel for our November newsletter, and submitted an abstract to SHM and SGIM.
HOMERuN collaborators supporting multiple scholarly projects and grant submissions:
  • Discharge Planning group has analyzed response to their Postdischarge Monitoring Follow-up Survey. Members are drafting a manuscript on their findings.
  • Workforce Planning group is analyzing response to their Jeopardy survey, writing a paper on the impact of COVID on women in medicine, writing a paper discussing the impact of the Omicron surge, and analyzing focus groups on parental leave policies.
  • Antiracism, Health Equity, and Justice group, in collaboration with the Workforce Planning Group, submitted a workshop for SHM which was accepted, and submitted a workshop for SGIM.
  • Provider Wellness group is developing a survey to division leaders regarding wellness initiatives.
  • Patient Experience Group and PFAC are working closely with new research projects looking at diagnostic errors and interhospital transfers.
  • Medical Education group is abstracting themes from faculty development focus groups and developing a new academic hospitalist onboarding survey.
  • No jinxes but — Marisha Burden and Angela Keniston submitted two separate grants seeking to examine the relationship between physician staffing and patient and physician outcomes.
Supported more than $7M in new grant funding:
In addition to supporting the ongoing UPSIDE study, HOMERuN investigators successfully competed for more than $7M in newly funded research. Both funded by AHRQ, one will examine how interhospital transfers might be improved, and the other will leverage learnings from our UPSIDE study to implement diagnostic process improvement into safety programs at HOMERuN sites.
HOMERuN strategic projects:
HOMERuN leadership, with contributions from across HOMERuN's teams, continue to develop strategic projects focused on accelerating the growth of academic Hospital Medicine. Examples of this work include surveys of hospital CEOs, planning NASEM conferences, developing a Hospital Scholar program, and supporting a benchmarking survey of academic Hospital Medicine groups.
Most importantly, we got to see each other in Nashville:
HOMERuN-Affiliated Study Seeking Partners
Roflumilast or Azithromycin to Prevent COPD Exacerbations (RELIANCE) Study
Purpose of RELIANCE:
Both roflumilast and azithromycin have been shown to reduce the risk of COPD exacerbations compared to placebo. However, there has not been a head-to-head comparison of these two FDA-approved medications. RELIANCE is intended to support hospital efforts to reduce the risk of all-cause hospitalization and premature deaths in individuals with COPD. 

RELIANCE is Seeking Community-Based Hospitalists:
Hospitalists are critical in the development of post-discharge care plans and medications used by people with COPD. We found from preliminary work that identification of people with COPD while they are hospitalized is an efficient recruitment method for RELIANCE.

Benefits and Compensation:
  • $500/year honorarium for being a community partner (paid after registration) plus $2,000 per patient enrolled.
  • Option to participate in clinical roundtables with COPD thought leaders.
  • Contribute topic ideas for future grant proposals or publications related to hospitalist care.
  • Community Partners will not be investigators / authors, but will be acknowledged in the RELIANCE publication. 

Please reach out to if you are interested in participating and would like more information about RELIANCE.
Our next meeting will be on January 13, 2023.
Image Attributions: Vector images from; Pulse Oximeter via Unsplash
Check out the HOMERuN website for more information.
If you would like to join the HOMERuN Collaborative calls, please reach out to